Events calendar

David Redfern, President Corporate Development, will attend the Barclays European Leadership Conference, taking place in London on Thursday, 21 May 2026.

Following EASL on 28th May, we are hosting a call with Nina Mojas, President, Global Product Strategy, Kaivan Khavandi, SVP, R&D Head Respiratory, Immunology & Inflammation, Melanie Paff, VP, MDL HBV Program and Prof Seng Gee Lim, Director of Hepatology, National University Health System, Singapore, highlighting our data from the B-Well 1 and B-Well 2 phase III pivotal studies on Thursday, 28 May 2026 at 3:00 pm BST / 10:00 am EDT (60 minutes).

Hesham Abdullah, SVP, Global Oncology R&D, will participate at the Jefferies Global Healthcare Conference in New York on Wednesday, 3 June 2026.

Julie Brown, Chief Financial Officer, will attend the BNP Paribas Exane CEO Conference in Paris on Wednesday, 3 June 2026.

Luke Miels, Chief Executive Officer, will attend the Citi European Healthcare CEO Conference in London on Wednesday, 10 June 2026.

We will announce our second quarter results on Wednesday, 29 July 2026.

We will announce our third quarter results on Wednesday, 28 October 2026.

We will announce our full year and fourth quarter results on Wednesday, 3 February 2027.